Delivery Order SPE2DE22D0008-SPE2D626F4J7B

The Defense Logistics Agency Medical Supply Chain issued a delivery order to Alba Bioscience, Inc. on April 16, 2026, with a ceiling value of $1,123.00 for ALBACLONE anti-A immunohematology reagent, with final completion due April 21, 2026. Place of performance is Chicago, IL 60607. Pricing is firm fixed price under the order's parent delivery mechanism. Alba Bioscience manufactures and supplies blood banking diagnostics and immunohematology reagents to federal healthcare systems as a prime...

<p>The Defense Logistics Agency's Medical Supply Chain issued a $6,943 delivery order to Alba Bioscience, Inc. on March 2, 2026, for ALBACLONE Anti-S monoclonal antibodies, with an ultimate completion date of March 5, 2026.</p> <p>Place of performance is Chicago, IL. Alba Bioscience specializes in immunohematology reagents and blood banking diagnostic materials for federal healthcare systems. The order is priced on a firm fixed price basis with no set-aside designation.</p>

The Defense Logistics Agency's Medical Supply Chain issued a $1,156.60 delivery order to Alba Bioscience, Inc. on March 24, 2026, for ALBACLONE Anti-LEA monoclonal antibodies, with ultimate completion on March 27, 2026. Place of performance is Chicago, IL 60607. Alba Bioscience specializes in immunohematology reagents and blood banking diagnostic products for federal healthcare systems, including monoclonal antibodies targeting various blood group antigens, antibody identification and...

The Defense Logistics Agency's Medical Supply Chain division issued a $1,750 delivery order to Alba Bioscience, Inc. on March 12, 2026, for ALBACLONE Anti-C monoclonal antibody reagent, with completion by March 17, 2026. Place of performance is Chicago, IL. Alba Bioscience supplies immunohematology reagents and blood banking diagnostic materials to federal healthcare systems, including monoclonal antibodies, antibody identification and screening panels, quality control kits, and specialized cell...

The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,370.00 to Alba Bioscience, Inc. for ALBACLONE Anti-A antibodies, with performance completion targeted for August 19, 2025. This non-set-aside contract represents a firm fixed price delivery order for specialized blood banking diagnostic reagents to be delivered to Chicago, Illinois. Alba Bioscience, a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., has established itself as a critical...

The Defense Logistics Agency's Medical Supply Chain division awarded a $1,194.00 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-D Blend, a monoclonal antibody reagent used in blood banking and immunohematology testing. The contract is structured as a firm fixed-price delivery order with a completion date of January 30, 2026, and was awarded on January 27, 2026. This award carries no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier...

The Defense Logistics Agency's Medical Supply Chain division awarded a $1,422.00 delivery order contract to Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics specializing in in vitro diagnostic products and blood banking materials. The award, issued on December 12, 2025, with an ultimate completion date of December 17, 2025, is for ALBACLONE Anti-A monoclonal antibodies used in blood typing and immunohematology testing. This firm fixed-price delivery order carries no...

<p>The Defense Logistics Agency's Medical Supply Chain issued a $5,805 delivery order to Alba Bioscience, Inc. on March 13, 2026, for an Albacyte Antibody ID Panel (10-cell) with an ultimate completion date of May 15, 2026.</p> <p>Place of performance is Chicago, IL 60607. The order is firm fixed price with no set-aside designation.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a $4,640 delivery order to Alba Bioscience, Inc. on April 30, 2026, for Albacyte antibody screen (2-cell) reagent supply, with completion by July 7, 2026.</p> <p>Place of performance is Chicago, IL. The order is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,250 to Alba Bioscience, Inc. on February 2, 2026, for the supply of ALBACLONE Anti-C (BIG C) monoclonal antibodies. The contract is a firm fixed-price delivery order with an ultimate completion date of February 5, 2026, and will be performed at the vendor's facility in Chicago, Illinois. No set-aside designation was used in this competitive procurement. Alba Bioscience, a Chicago-based subsidiary...